| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $123.12K | – | – | – | – |
| SG&A | $853.00 | $11.48K | $2.63K | $7.03K | $7.47K |
| Operating Income | – | – | -$62.94K | -$155.52K | -$309.32K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$341.86K | -$79.05K | -$62.94K | $2.03M | -$2.57M |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |